Minnesota Statewide Cardiovascular Summit


Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.

Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people’s lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world’s leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.


Delivering optimal cardiovascular care, research, and education to improve the health of our community through patient-focused, digitally supported, and data-driven innovation.

Handout: World-class cardiovascular care: Setting the standard (PDF)


The American Heart Association gratefully acknowledges the financial commitment and support of the following organizations for the Conference.